John Saharek P.'s most recent trade in Harrow Health Inc was a trade of 277,200 Performance Stock Unit done . Disclosure was reported to the exchange on April 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Harrow Health Inc | John Saharek P. | CEO & President, ImprimisRx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2025 | 277,200 | 0 | - | - | Performance Stock Unit | |
| Harrow Health Inc | John Saharek P. | CEO & President, ImprimisRx | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2025 | 277,200 | 576,863 (2%) | 1% | 0 | Common Stock | |
| Harrow Health Inc | John Saharek P. | CEO & President, ImprimisRx | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.09 per share. | 03 Apr 2025 | 109,475 | 467,388 (1%) | 0% | 23.1 | 2,527,778 | Common Stock |